$HARP Insider Trading
FREE EMAIL WATCHDOG
Get free email notifications about insider trading in Harpoon Therapeutics, Inc..
- Your email is safe with us.
- The service is free and you can unsubscribe at any time.
General | Insiders | Insider Transactions | Monthly Overview | Weekly Overview
Overview of all insider trading transactions in Harpoon Therapeutics, Inc.. Get notifications about new insider transactions in Harpoon Therapeutics, Inc. for free.
Date | Ticker | Company | Owner | Relationship | Transaction | Code | Cost ($) | Shares | Transaction Value ($) | Total Shares | % Holdings |
---|---|---|---|---|---|---|---|---|---|---|---|
May 24 2021 | HARP | Harpoon Therapeuti ... | GADICKE ANSBERT | 10% Owner | Sell | S | 20.12 | 5,000 | 100,600 | 6,402,748 | 6.4 M to 6.4 M (-0.08 %) |
May 24 2021 | HARP | Harpoon Therapeuti ... | GADICKE ANSBERT | 10% Owner | Sell | S | 20.21 | 10,907 | 220,430 | 6,407,748 | 6.4 M to 6.4 M (-0.17 %) |
May 12 2021 | HARP | Harpoon Therapeuti ... | GADICKE ANSBERT | 10% Owner | Sell | S | 20.53 | 29,684 | 609,413 | 6,483,024 | 6.5 M to 6.5 M (-0.46 %) |
May 12 2021 | HARP | Harpoon Therapeuti ... | GADICKE ANSBERT | 10% Owner | Sell | S | 21.51 | 7,672 | 165,025 | 6,512,708 | 6.5 M to 6.5 M (-0.12 %) |
May 12 2021 | HARP | Harpoon Therapeuti ... | GADICKE ANSBERT | 10% Owner | Sell | S | 20.96 | 13,773 | 288,682 | 6,520,380 | 6.5 M to 6.5 M (-0.21 %) |
May 12 2021 | HARP | Harpoon Therapeuti ... | GADICKE ANSBERT | 10% Owner | Sell | S | 22.46 | 411 | 9,231 | 6,534,153 | 6.5 M to 6.5 M (-0.01 %) |
May 12 2021 | HARP | Harpoon Therapeuti ... | GADICKE ANSBERT | 10% Owner | Sell | S | 21.78 | 16,722 | 364,205 | 6,534,564 | 6.6 M to 6.5 M (-0.26 %) |
May 07 2021 | HARP | Harpoon Therapeuti ... | Colowick Alan | Director | Option Exercise | A | 22.50 | 10,167 | 228,758 | 10,167 | |
May 07 2021 | HARP | Harpoon Therapeuti ... | Viney Joanne L. | Director | Option Exercise | A | 22.50 | 2,653 | 59,693 | 2,653 | |
May 07 2021 | HARP | Harpoon Therapeuti ... | Viney Joanne L. | Director | Option Exercise | A | 22.50 | 10,167 | 228,758 | 10,167 | |
May 07 2021 | HARP | Harpoon Therapeuti ... | BAILES JOSEPH S | Director | Option Exercise | A | 22.50 | 10,167 | 228,758 | 10,167 | |
May 07 2021 | HARP | Harpoon Therapeuti ... | Robbins Andrew R | Director | Option Exercise | A | 22.50 | 10,167 | 228,758 | 10,167 | |
May 07 2021 | HARP | Harpoon Therapeuti ... | Myers Scott Dunseth | Director | Option Exercise | A | 22.50 | 10,167 | 228,758 | 10,167 | |
May 07 2021 | HARP | Harpoon Therapeuti ... | EASTLAND JULIA MARIE | Director | Option Exercise | A | 22.50 | 10,167 | 228,758 | 10,167 | |
May 07 2021 | HARP | Harpoon Therapeuti ... | HUNT RONALD | Director | Option Exercise | A | 22.50 | 4,807 | 108,158 | 4,807 | |
May 07 2021 | HARP | Harpoon Therapeuti ... | HUNT RONALD | Director | Option Exercise | A | 22.50 | 10,167 | 228,758 | 10,167 | |
May 07 2021 | HARP | Harpoon Therapeuti ... | DRACHMAN JONATHAN G | Director | Option Exercise | A | 22.50 | 10,167 | 228,758 | 10,167 | |
May 07 2021 | HARP | Harpoon Therapeuti ... | Chin Mark | Director | Option Exercise | A | 22.50 | 3,017 | 67,883 | 3,017 | |
May 07 2021 | HARP | Harpoon Therapeuti ... | Chin Mark | Director | Option Exercise | A | 22.50 | 10,167 | 228,758 | 10,167 | |
May 04 2021 | HARP | Harpoon Therapeuti ... | GADICKE ANSBERT | 10% Owner | Sell | S | 23.33 | 3,500 | 81,655 | 6,561,458 | 6.6 M to 6.6 M (-0.05 %) |
May 04 2021 | HARP | Harpoon Therapeuti ... | GADICKE ANSBERT | 10% Owner | Sell | S | 23.03 | 26,230 | 604,077 | 6,564,958 | 6.6 M to 6.6 M (-0.40 %) |
May 04 2021 | HARP | Harpoon Therapeuti ... | GADICKE ANSBERT | 10% Owner | Sell | S | 23.45 | 4,401 | 103,203 | 6,591,188 | 6.6 M to 6.6 M (-0.07 %) |
May 04 2021 | HARP | Harpoon Therapeuti ... | GADICKE ANSBERT | 10% Owner | Sell | S | 23.03 | 26,365 | 607,186 | 6,595,589 | 6.6 M to 6.6 M (-0.40 %) |
May 04 2021 | HARP | Harpoon Therapeuti ... | GADICKE ANSBERT | 10% Owner | Sell | S | 22.35 | 268,023 | 5,990,314 | 6,621,954 | 6.9 M to 6.6 M (-3.89 %) |
Apr 29 2021 | HARP | Harpoon Therapeuti ... | GADICKE ANSBERT | 10% Owner | Sell | S | 22.54 | 21,781 | 490,944 | 6,889,977 | 6.9 M to 6.9 M (-0.32 %) |
Apr 29 2021 | HARP | Harpoon Therapeuti ... | GADICKE ANSBERT | 10% Owner | Sell | S | 22.02 | 45,511 | 1,002,152 | 6,911,758 | 7 M to 6.9 M (-0.65 %) |
Apr 29 2021 | HARP | Harpoon Therapeuti ... | GADICKE ANSBERT | 10% Owner | Sell | S | 22.01 | 36,803 | 810,034 | 6,957,269 | 7 M to 7 M (-0.53 %) |
Apr 29 2021 | HARP | Harpoon Therapeuti ... | GADICKE ANSBERT | 10% Owner | Sell | S | 21.64 | 14,219 | 307,699 | 6,994,072 | 7 M to 7 M (-0.20 %) |
Apr 29 2021 | HARP | Harpoon Therapeuti ... | GADICKE ANSBERT | 10% Owner | Sell | S | 21.26 | 8,328 | 177,053 | 7,008,291 | 7 M to 7 M (-0.12 %) |
Apr 29 2021 | HARP | Harpoon Therapeuti ... | GADICKE ANSBERT | 10% Owner | Sell | S | 20.99 | 3,501 | 73,486 | 7,016,619 | 7 M to 7 M (-0.05 %) |
Apr 20 2021 | HARP | Harpoon Therapeuti ... | GADICKE ANSBERT | 10% Owner | Sell | S | 19.09 | 834 | 15,921 | 7,029,092 | 7 M to 7 M (-0.01 %) |
Apr 20 2021 | HARP | Harpoon Therapeuti ... | GADICKE ANSBERT | 10% Owner | Sell | S | 18.70 | 21,415 | 400,461 | 7,029,926 | 7.1 M to 7 M (-0.30 %) |
Apr 20 2021 | HARP | Harpoon Therapeuti ... | GADICKE ANSBERT | 10% Owner | Sell | S | 20.08 | 100 | 2,008 | 7,051,341 | 7.1 M to 7.1 M (0.00 %) |
Apr 20 2021 | HARP | Harpoon Therapeuti ... | GADICKE ANSBERT | 10% Owner | Sell | S | 19.29 | 9,956 | 192,051 | 7,051,441 | 7.1 M to 7.1 M (-0.14 %) |
Apr 20 2021 | HARP | Harpoon Therapeuti ... | GADICKE ANSBERT | 10% Owner | Sell | S | 20.56 | 300 | 6,168 | 7,061,397 | 7.1 M to 7.1 M (0.00 %) |
Apr 20 2021 | HARP | Harpoon Therapeuti ... | GADICKE ANSBERT | 10% Owner | Sell | S | 19.82 | 5,547 | 109,942 | 7,061,697 | 7.1 M to 7.1 M (-0.08 %) |
Apr 15 2021 | HARP | Harpoon Therapeuti ... | MPM BioVentures 2014, L.P. | Sell | S | 20.49 | 1,052 | 21,555 | 3,220,844 | 3.2 M to 3.2 M (-0.03 %) | |
Apr 15 2021 | HARP | Harpoon Therapeuti ... | MPM BioVentures 2014, L.P. | Sell | S | 20.83 | 1,550 | 32,287 | 3,221,896 | 3.2 M to 3.2 M (-0.05 %) | |
Apr 15 2021 | HARP | Harpoon Therapeuti ... | MPM BioVentures 2014, L.P. | Sell | S | 20.06 | 121 | 2,427 | 3,223,446 | 3.2 M to 3.2 M (0.00 %) | |
Apr 15 2021 | HARP | Harpoon Therapeuti ... | MPM BioVentures 2014, L.P. | Sell | S | 20.08 | 286 | 5,743 | 3,223,567 | 3.2 M to 3.2 M (-0.01 %) | |
Apr 15 2021 | HARP | Harpoon Therapeuti ... | MPM BioVentures 2014, L.P. | Sell | S | 19.35 | 1,657 | 32,063 | 3,223,853 | 3.2 M to 3.2 M (-0.05 %) | |
Apr 15 2021 | HARP | Harpoon Therapeuti ... | GADICKE ANSBERT | 10% Owner | Sell | S | 20.49 | 8,696 | 178,181 | 7,067,244 | 7.1 M to 7.1 M (-0.12 %) |
Apr 15 2021 | HARP | Harpoon Therapeuti ... | GADICKE ANSBERT | 10% Owner | Sell | S | 20.83 | 12,806 | 266,749 | 7,075,940 | 7.1 M to 7.1 M (-0.18 %) |
Apr 15 2021 | HARP | Harpoon Therapeuti ... | GADICKE ANSBERT | 10% Owner | Sell | S | 20.06 | 1,000 | 20,060 | 7,088,746 | 7.1 M to 7.1 M (-0.01 %) |
Apr 15 2021 | HARP | Harpoon Therapeuti ... | GADICKE ANSBERT | 10% Owner | Sell | S | 20.08 | 2,362 | 47,429 | 7,089,746 | 7.1 M to 7.1 M (-0.03 %) |
Apr 15 2021 | HARP | Harpoon Therapeuti ... | GADICKE ANSBERT | 10% Owner | Sell | S | 19.35 | 13,692 | 264,940 | 7,092,108 | 7.1 M to 7.1 M (-0.19 %) |
Apr 13 2021 | HARP | Harpoon Therapeuti ... | GADICKE ANSBERT | 10% Owner | Sell | S | 22.68 | 400 | 9,072 | 7,105,800 | 7.1 M to 7.1 M (-0.01 %) |
Apr 13 2021 | HARP | Harpoon Therapeuti ... | GADICKE ANSBERT | 10% Owner | Sell | S | 21.52 | 6,700 | 144,184 | 7,106,200 | 7.1 M to 7.1 M (-0.09 %) |
Apr 13 2021 | HARP | Harpoon Therapeuti ... | GADICKE ANSBERT | 10% Owner | Sell | S | 20.72 | 13,528 | 280,300 | 7,112,900 | 7.1 M to 7.1 M (-0.19 %) |
Apr 13 2021 | HARP | Harpoon Therapeuti ... | GADICKE ANSBERT | 10% Owner | Sell | S | 23.67 | 10,300 | 243,801 | 7,126,428 | 7.1 M to 7.1 M (-0.14 %) |
Apr 13 2021 | HARP | Harpoon Therapeuti ... | MPM BioVentures 2014, L.P. | 10% Owner | Sell | S | 22.68 | 48 | 1,089 | 3,225,510 | 3.2 M to 3.2 M (0.00 %) |
Apr 13 2021 | HARP | Harpoon Therapeuti ... | MPM BioVentures 2014, L.P. | 10% Owner | Sell | S | 21.52 | 811 | 17,453 | 3,225,558 | 3.2 M to 3.2 M (-0.03 %) |
Apr 13 2021 | HARP | Harpoon Therapeuti ... | MPM BioVentures 2014, L.P. | 10% Owner | Sell | S | 20.72 | 1,637 | 33,919 | 3,226,369 | 3.2 M to 3.2 M (-0.05 %) |
Apr 13 2021 | HARP | Harpoon Therapeuti ... | MPM BioVentures 2014, L.P. | 10% Owner | Sell | S | 23.67 | 10,300 | 243,801 | 3,228,006 | 3.2 M to 3.2 M (-0.32 %) |
Apr 05 2021 | HARP | Harpoon Therapeuti ... | Wesche Holger | Chief Scientific Of ... | Option Exercise | M | 0.60 | 1,534 | 920 | 31,002 | |
Apr 05 2021 | HARP | Harpoon Therapeuti ... | Wesche Holger | Chief Scientific Of ... | Option Exercise | M | 0.60 | 8,466 | 5,080 | 2,540 | |
Apr 05 2021 | HARP | Harpoon Therapeuti ... | Wesche Holger | Chief Scientific Of ... | Sell | S | 21.14 | 500 | 10,570 | 52,852 | 53.4 K to 52.9 K (-0.94 %) |
Apr 05 2021 | HARP | Harpoon Therapeuti ... | Wesche Holger | Chief Scientific Of ... | Sell | S | 20.41 | 9,500 | 193,921 | 53,352 | 62.9 K to 53.4 K (-15.11 %) |
Apr 05 2021 | HARP | Harpoon Therapeuti ... | Wesche Holger | Chief Scientific Of ... | Buy | M | 0.60 | 1,534 | 920 | 62,852 | 61.3 K to 62.9 K (+2.50 %) |
Apr 05 2021 | HARP | Harpoon Therapeuti ... | Wesche Holger | Chief Scientific Of ... | Buy | M | 0.60 | 8,466 | 5,080 | 61,318 | 52.9 K to 61.3 K (+16.02 %) |
Mar 26 2021 | HARP | Harpoon Therapeuti ... | Colowick Alan | Director | Option Exercise | A | 19.63 | 20,335 | 399,176 | 20,335 | |
Feb 18 2021 | HARP | Harpoon Therapeuti ... | Erbez Georgia | Chief Financial Off ... | Option Exercise | M | 2.12 | 25,000 | 53,000 | 145,908 | |
Feb 18 2021 | HARP | Harpoon Therapeuti ... | Erbez Georgia | Chief Financial Off ... | Buy | M | 2.12 | 25,000 | 53,000 | 72,292 | 47.3 K to 72.3 K (+52.86 %) |
Feb 12 2021 | HARP | Harpoon Therapeuti ... | MPM BioVentures 2014, L.P. | 10% Owner | Sell | S | 20.00 | 183,051 | 3,661,020 | 3,238,306 | 3.4 M to 3.2 M (-5.35 %) |
Feb 09 2021 | HARP | Harpoon Therapeuti ... | MPM BioVentures 2014, L.P. | 10% Owner | Sell | S | 20.25 | 9,400 | 190,350 | 3,421,357 | 3.4 M to 3.4 M (-0.27 %) |
Feb 09 2021 | HARP | Harpoon Therapeuti ... | MPM BioVentures 2014, L.P. | 10% Owner | Sell | S | 20.04 | 72,128 | 1,445,445 | 3,430,757 | 3.5 M to 3.4 M (-2.06 %) |
Feb 09 2021 | HARP | Harpoon Therapeuti ... | MPM BioVentures 2014, L.P. | 10% Owner | Sell | S | 20.01 | 10,172 | 203,542 | 3,502,885 | 3.5 M to 3.5 M (-0.29 %) |
Feb 04 2021 | HARP | Harpoon Therapeuti ... | MPM BioVentures 2014, L.P. | 10% Owner | Sell | S | 20.37 | 29,730 | 605,600 | 3,513,057 | 3.5 M to 3.5 M (-0.84 %) |
Feb 04 2021 | HARP | Harpoon Therapeuti ... | MPM BioVentures 2014, L.P. | 10% Owner | Sell | S | 20.21 | 41,922 | 847,244 | 3,542,787 | 3.6 M to 3.5 M (-1.17 %) |
Feb 04 2021 | HARP | Harpoon Therapeuti ... | MPM BioVentures 2014, L.P. | 10% Owner | Sell | S | 20.13 | 48,421 | 974,715 | 3,584,709 | 3.6 M to 3.6 M (-1.33 %) |
Jan 29 2021 | HARP | Harpoon Therapeuti ... | Wesche Holger | Chief Scientific Of ... | Option Exercise | A | 18.66 | 52,000 | 970,320 | 52,000 | |
Jan 29 2021 | HARP | Harpoon Therapeuti ... | Sacks Natalie | Chief Medical Offic ... | Option Exercise | A | 18.66 | 80,000 | 1,492,800 | 80,000 | |
Jan 29 2021 | HARP | Harpoon Therapeuti ... | Erbez Georgia | Chief Financial Off ... | Option Exercise | A | 18.66 | 72,000 | 1,343,520 | 72,000 | |
Jan 29 2021 | HARP | Harpoon Therapeuti ... | McMahon Gerald PhD | President and CEO | Option Exercise | A | 18.66 | 181,470 | 3,386,230 | 181,470 | |
Jan 27 2021 | HARP | Harpoon Therapeuti ... | MPM BioVentures 2014, L.P. | 10% Owner | Sell | S | 20.00 | 706,825 | 14,136,500 | 3,633,130 | 4.3 M to 3.6 M (-16.29 %) |
Jan 27 2021 | HARP | Harpoon Therapeuti ... | MPM BioVentures 2014, L.P. | 10% Owner | Sell | S | 21.08 | 1,363 | 28,732 | 4,339,955 | 4.3 M to 4.3 M (-0.03 %) |
Jan 27 2021 | HARP | Harpoon Therapeuti ... | MPM BioVentures 2014, L.P. | 10% Owner | Sell | S | 21.23 | 13,006 | 276,117 | 4,341,318 | 4.4 M to 4.3 M (-0.30 %) |
Jan 22 2021 | HARP | Harpoon Therapeuti ... | MPM BioVentures 2014, L.P. | 10% Owner | Sell | S | 21.72 | 24,695 | 536,375 | 4,354,324 | 4.4 M to 4.4 M (-0.56 %) |
Jan 22 2021 | HARP | Harpoon Therapeuti ... | MPM BioVentures 2014, L.P. | 10% Owner | Sell | S | 23.77 | 200 | 4,754 | 4,379,019 | 4.4 M to 4.4 M (0.00 %) |
Jan 22 2021 | HARP | Harpoon Therapeuti ... | MPM BioVentures 2014, L.P. | 10% Owner | Sell | S | 22.61 | 4,887 | 110,495 | 4,379,219 | 4.4 M to 4.4 M (-0.11 %) |
Jan 22 2021 | HARP | Harpoon Therapeuti ... | MPM BioVentures 2014, L.P. | 10% Owner | Sell | S | 22.11 | 20,979 | 463,846 | 4,384,106 | 4.4 M to 4.4 M (-0.48 %) |
Jan 22 2021 | HARP | Harpoon Therapeuti ... | MPM BioVentures 2014, L.P. | 10% Owner | Sell | J | 0.00 | 101,646 | 0 | 4,405,085 | 4.5 M to 4.4 M (-2.26 %) |
Jan 22 2021 | HARP | Harpoon Therapeuti ... | MPM BioVentures 2014, L.P. | 10% Owner | Sell | S | 24.71 | 2,000 | 49,420 | 4,506,731 | 4.5 M to 4.5 M (-0.04 %) |
Jan 22 2021 | HARP | Harpoon Therapeuti ... | MPM BioVentures 2014, L.P. | 10% Owner | Sell | S | 23.95 | 15,694 | 375,871 | 4,508,731 | 4.5 M to 4.5 M (-0.35 %) |
Oct 05 2020 | HARP | Harpoon Therapeuti ... | Wesche Holger | Chief Scientific Of ... | Option Exercise | M | 0.60 | 10,000 | 6,000 | 21,006 | |
Oct 05 2020 | HARP | Harpoon Therapeuti ... | Wesche Holger | Chief Scientific Of ... | Sell | S | 17.03 | 1,000 | 17,030 | 52,669 | 53.7 K to 52.7 K (-1.86 %) |
Oct 05 2020 | HARP | Harpoon Therapeuti ... | Wesche Holger | Chief Scientific Of ... | Sell | S | 16.19 | 9,000 | 145,707 | 53,669 | 62.7 K to 53.7 K (-14.36 %) |
Oct 05 2020 | HARP | Harpoon Therapeuti ... | Wesche Holger | Chief Scientific Of ... | Buy | M | 0.60 | 10,000 | 6,000 | 62,669 | 52.7 K to 62.7 K (+18.99 %) |
Aug 20 2020 | HARP | Harpoon Therapeuti ... | Erbez Georgia | Chief Financial Off ... | Buy | P | 11.40 | 5,000 | 57,000 | 8,915 | 3.9 K to 8.9 K (+127.71 %) |
Aug 20 2020 | HARP | Harpoon Therapeuti ... | Erbez Georgia | Chief Financial Off ... | Buy | P | 11.60 | 2,098 | 24,337 | 3,915 | 1.8 K to 3.9 K (+115.47 %) |
Aug 04 2020 | HARP | Harpoon Therapeuti ... | Erbez Georgia | Chief Financial Off ... | Buy | P | 10.92 | 1,817 | 19,842 | 1,817 | 0 to 1.8 K |
Jul 02 2020 | HARP | Harpoon Therapeuti ... | Wesche Holger | Chief Scientific Of ... | Option Exercise | M | 0.60 | 10,000 | 6,000 | 31,006 | |
Jul 02 2020 | HARP | Harpoon Therapeuti ... | Wesche Holger | Chief Scientific Of ... | Sell | S | 16.20 | 10,000 | 161,989 | 52,669 | 62.7 K to 52.7 K (-15.96 %) |
Jul 02 2020 | HARP | Harpoon Therapeuti ... | Wesche Holger | Chief Scientific Of ... | Buy | M | 0.60 | 10,000 | 6,000 | 62,669 | 52.7 K to 62.7 K (+18.99 %) |
Jul 02 2020 | HARP | Harpoon Therapeuti ... | Viney Joanne L. | Director | Option Exercise | A | 17.49 | 20,335 | 355,659 | 20,335 | |
Jun 01 2020 | HARP | Harpoon Therapeuti ... | Myers Scott Dunseth | Director | Option Exercise | A | 20.59 | 10,167 | 209,339 | 10,167 | |
Jun 01 2020 | HARP | Harpoon Therapeuti ... | EASTLAND JULIA MARIE | Director | Option Exercise | A | 20.59 | 10,167 | 209,339 | 10,167 | |
Jun 01 2020 | HARP | Harpoon Therapeuti ... | HUNT RONALD | Director | Option Exercise | A | 20.59 | 4,906 | 101,015 | 4,906 | |
Jun 01 2020 | HARP | Harpoon Therapeuti ... | HUNT RONALD | Director | Option Exercise | A | 20.59 | 10,167 | 209,339 | 10,167 | |
Jun 01 2020 | HARP | Harpoon Therapeuti ... | DRACHMAN JONATHAN G | Director | Option Exercise | A | 20.59 | 2,880 | 59,299 | 2,880 | |
Jun 01 2020 | HARP | Harpoon Therapeuti ... | DRACHMAN JONATHAN G | Director | Option Exercise | A | 20.59 | 10,167 | 209,339 | 10,167 | |
Jun 01 2020 | HARP | Harpoon Therapeuti ... | Chin Mark | Director | Option Exercise | A | 20.59 | 3,017 | 62,120 | 3,017 | |
Jun 01 2020 | HARP | Harpoon Therapeuti ... | Chin Mark | Director | Option Exercise | A | 20.59 | 10,167 | 209,339 | 10,167 | |
Jun 01 2020 | HARP | Harpoon Therapeuti ... | Baeuerle Patrick | Director | Option Exercise | A | 20.59 | 2,584 | 53,205 | 2,584 | |
Jun 01 2020 | HARP | Harpoon Therapeuti ... | Baeuerle Patrick | Director | Option Exercise | A | 20.59 | 10,167 | 209,339 | 10,167 | |
Jun 01 2020 | HARP | Harpoon Therapeuti ... | EVNIN LUKE | Director | Option Exercise | A | 20.59 | 3,587 | 73,856 | 3,587 | |
Jun 01 2020 | HARP | Harpoon Therapeuti ... | EVNIN LUKE | Director | Option Exercise | A | 20.59 | 10,167 | 209,339 | 10,167 | |
May 29 2020 | HARP | Harpoon Therapeuti ... | Arix Bioscience plc | 10% Owner | Sell | S | 21.33 | 366,591 | 7,820,926 | 2,193,704 | 2.6 M to 2.2 M (-14.32 %) |
May 29 2020 | HARP | Harpoon Therapeuti ... | Arix Bioscience plc | 10% Owner | Sell | S | 22.39 | 12,064 | 270,144 | 2,560,295 | 2.6 M to 2.6 M (-0.47 %) |
May 20 2020 | HARP | Harpoon Therapeuti ... | Sacks Natalie | Chief Medical Offic ... | Option Exercise | M | 2.12 | 1,522 | 3,227 | 45,625 | |
May 20 2020 | HARP | Harpoon Therapeuti ... | Sacks Natalie | Chief Medical Offic ... | Sell | S | 14.77 | 1,522 | 22,479 | 45,754 | 47.3 K to 45.8 K (-3.22 %) |
May 20 2020 | HARP | Harpoon Therapeuti ... | Sacks Natalie | Chief Medical Offic ... | Buy | M | 2.12 | 1,522 | 3,227 | 47,276 | 45.8 K to 47.3 K (+3.33 %) |
May 13 2020 | HARP | Harpoon Therapeuti ... | Wesche Holger | Chief Scientific Of ... | Option Exercise | M | 0.60 | 1,400 | 840 | 41,006 | |
May 13 2020 | HARP | Harpoon Therapeuti ... | Wesche Holger | Chief Scientific Of ... | Sell | S | 14.09 | 1,400 | 19,720 | 52,669 | 54.1 K to 52.7 K (-2.59 %) |
May 13 2020 | HARP | Harpoon Therapeuti ... | Wesche Holger | Chief Scientific Of ... | Buy | M | 0.60 | 1,400 | 840 | 54,069 | 52.7 K to 54.1 K (+2.66 %) |
May 13 2020 | HARP | Harpoon Therapeuti ... | Wesche Holger | Chief Scientific Of ... | Option Exercise | M | 0.60 | 1,400 | 840 | 41,006 | |
May 13 2020 | HARP | Harpoon Therapeuti ... | Wesche Holger | Chief Scientific Of ... | Sell | S | 14.09 | 1,400 | 19,720 | 52,669 | 54.1 K to 52.7 K (-2.59 %) |
May 13 2020 | HARP | Harpoon Therapeuti ... | Wesche Holger | Chief Scientific Of ... | Buy | M | 0.60 | 1,400 | 840 | 54,069 | 52.7 K to 54.1 K (+2.66 %) |
May 11 2020 | HARP | Harpoon Therapeuti ... | Wesche Holger | Chief Scientific Of ... | Option Exercise | M | 0.60 | 1,000 | 600 | 42,406 | |
May 11 2020 | HARP | Harpoon Therapeuti ... | Wesche Holger | Chief Scientific Of ... | Option Exercise | M | 0.60 | 1,000 | 600 | 42,406 | |
May 11 2020 | HARP | Harpoon Therapeuti ... | Wesche Holger | Chief Scientific Of ... | Option Exercise | M | 0.60 | 1,000 | 600 | 43,406 | |
May 11 2020 | HARP | Harpoon Therapeuti ... | Wesche Holger | Chief Scientific Of ... | Option Exercise | M | 0.60 | 1,000 | 600 | 43,406 | |
May 11 2020 | HARP | Harpoon Therapeuti ... | Wesche Holger | Chief Scientific Of ... | Option Exercise | M | 0.60 | 5,350 | 3,210 | 44,406 | |
May 11 2020 | HARP | Harpoon Therapeuti ... | Wesche Holger | Chief Scientific Of ... | Option Exercise | M | 0.60 | 5,350 | 3,210 | 44,406 | |
May 11 2020 | HARP | Harpoon Therapeuti ... | Wesche Holger | Chief Scientific Of ... | Sell | S | 14.07 | 1,000 | 14,065 | 52,669 | 53.7 K to 52.7 K (-1.86 %) |
May 11 2020 | HARP | Harpoon Therapeuti ... | Wesche Holger | Chief Scientific Of ... | Sell | S | 14.07 | 1,000 | 14,065 | 52,669 | 53.7 K to 52.7 K (-1.86 %) |
May 11 2020 | HARP | Harpoon Therapeuti ... | Wesche Holger | Chief Scientific Of ... | Buy | M | 0.60 | 1,000 | 600 | 53,669 | 52.7 K to 53.7 K (+1.90 %) |
May 11 2020 | HARP | Harpoon Therapeuti ... | Wesche Holger | Chief Scientific Of ... | Buy | M | 0.60 | 1,000 | 600 | 53,669 | 52.7 K to 53.7 K (+1.90 %) |
May 11 2020 | HARP | Harpoon Therapeuti ... | Wesche Holger | Chief Scientific Of ... | Sell | S | 14.00 | 1,000 | 14,000 | 52,669 | 53.7 K to 52.7 K (-1.86 %) |
May 11 2020 | HARP | Harpoon Therapeuti ... | Wesche Holger | Chief Scientific Of ... | Sell | S | 14.00 | 1,000 | 14,000 | 52,669 | 53.7 K to 52.7 K (-1.86 %) |
May 11 2020 | HARP | Harpoon Therapeuti ... | Wesche Holger | Chief Scientific Of ... | Buy | M | 0.60 | 1,000 | 600 | 53,669 | 52.7 K to 53.7 K (+1.90 %) |
May 11 2020 | HARP | Harpoon Therapeuti ... | Wesche Holger | Chief Scientific Of ... | Buy | M | 0.60 | 1,000 | 600 | 53,669 | 52.7 K to 53.7 K (+1.90 %) |
May 11 2020 | HARP | Harpoon Therapeuti ... | Wesche Holger | Chief Scientific Of ... | Sell | S | 14.13 | 5,350 | 75,576 | 52,669 | 58 K to 52.7 K (-9.22 %) |
May 11 2020 | HARP | Harpoon Therapeuti ... | Wesche Holger | Chief Scientific Of ... | Sell | S | 14.13 | 5,350 | 75,576 | 52,669 | 58 K to 52.7 K (-9.22 %) |
May 11 2020 | HARP | Harpoon Therapeuti ... | Wesche Holger | Chief Scientific Of ... | Buy | M | 0.60 | 5,350 | 3,210 | 58,019 | 52.7 K to 58 K (+10.16 %) |
May 11 2020 | HARP | Harpoon Therapeuti ... | Wesche Holger | Chief Scientific Of ... | Buy | M | 0.60 | 5,350 | 3,210 | 58,019 | 52.7 K to 58 K (+10.16 %) |
Apr 30 2020 | HARP | Harpoon Therapeuti ... | Wesche Holger | Chief Scientific Of ... | Option Exercise | M | 0.60 | 1,250 | 750 | 49,756 | |
Apr 30 2020 | HARP | Harpoon Therapeuti ... | Wesche Holger | Chief Scientific Of ... | Sell | S | 14.05 | 1,250 | 17,565 | 52,669 | 53.9 K to 52.7 K (-2.32 %) |
Apr 30 2020 | HARP | Harpoon Therapeuti ... | Wesche Holger | Chief Scientific Of ... | Buy | M | 0.60 | 1,250 | 750 | 53,919 | 52.7 K to 53.9 K (+2.37 %) |
Apr 17 2020 | HARP | Harpoon Therapeuti ... | Sacks Natalie | Chief Medical Offic ... | Option Exercise | M | 2.12 | 1,021 | 2,165 | 47,147 | |
Apr 17 2020 | HARP | Harpoon Therapeuti ... | Sacks Natalie | Chief Medical Offic ... | Option Exercise | M | 2.12 | 500 | 1,060 | 48,168 | |
Apr 17 2020 | HARP | Harpoon Therapeuti ... | Sacks Natalie | Chief Medical Offic ... | Sell | S | 12.08 | 1,021 | 12,330 | 45,754 | 46.8 K to 45.8 K (-2.18 %) |
Apr 17 2020 | HARP | Harpoon Therapeuti ... | Sacks Natalie | Chief Medical Offic ... | Buy | M | 2.12 | 1,021 | 2,165 | 46,775 | 45.8 K to 46.8 K (+2.23 %) |
Apr 17 2020 | HARP | Harpoon Therapeuti ... | Sacks Natalie | Chief Medical Offic ... | Sell | S | 12.00 | 500 | 6,000 | 45,754 | 46.3 K to 45.8 K (-1.08 %) |
Apr 17 2020 | HARP | Harpoon Therapeuti ... | Sacks Natalie | Chief Medical Offic ... | Buy | M | 2.12 | 500 | 1,060 | 46,254 | 45.8 K to 46.3 K (+1.09 %) |
Apr 15 2020 | HARP | Harpoon Therapeuti ... | Sacks Natalie | Chief Medical Offic ... | Option Exercise | M | 2.12 | 4,556 | 9,659 | 174,752 | |
Apr 15 2020 | HARP | Harpoon Therapeuti ... | Sacks Natalie | Chief Medical Offic ... | Sell | S | 12.06 | 4,556 | 54,959 | 45,754 | 50.3 K to 45.8 K (-9.06 %) |
Apr 15 2020 | HARP | Harpoon Therapeuti ... | Sacks Natalie | Chief Medical Offic ... | Buy | M | 2.12 | 4,556 | 9,659 | 50,310 | 45.8 K to 50.3 K (+9.96 %) |
Apr 08 2020 | HARP | Harpoon Therapeuti ... | Sacks Natalie | Chief Medical Offic ... | Option Exercise | M | 2.12 | 570 | 1,208 | 179,308 | |
Apr 08 2020 | HARP | Harpoon Therapeuti ... | Sacks Natalie | Chief Medical Offic ... | Option Exercise | M | 2.12 | 700 | 1,484 | 179,878 |